Our data demonstrate that the beneficial effects of delayed kallikrein treatment are exerted via enhanced angiogenesis in the peri-infarction zone, and the distinct therapy effect of kallikein at different times after stroke is in accordance with the degree of vascular proliferation. Here, KLK4 is linked to infarction.